Table 2. Multivariate analysis of TGFβ1 polymorphisms and clinical outcome in NSCLC.

Polymorphism and Genotypes	Overall Survival			Distant Metastasis-Free Survival
	HR	95%CI	P	HR	95%CI	P
rs1800469 (C–509T)
CC (n = 125)	1.000			1.000
CT+TT (n = 80)	1.463	1.012–2.114	0.043	1.601	1.042–2.459	0.032
rs1800471 (G915C)
GG (n = 178)	1.000			1.000
CG+CC (n = 27)	0.730	0.413–1.291	0.280	0.758	0.395–1.454	0.404
rs1982073 (T+29C)
TT (n = 68)	1.000			1.000
CT+CC (n = 137)	1.271	0.873–1.851	0.211	1.589	1.009–2.502	0.046

Abbreviations: NSCLC, non-small cell lung cancer; HR, hazard ratio; CI, confidence interval.